Long-Acting Injectable Risperidone for the Treatment of Schizophrenia: Clinical Perspectives

ISSN： 0012-6667

Source： Drugs, Vol.67, Iss.11, 2007-01, pp. : 1541-1566

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Long-Acting Risperidone in Schizophrenia

By Tracy Swainston Harrison Karen L. Goa

American Journal of Drug Delivery, Vol. 2, Iss. 3, 2004-01 ,pp. : 207-210

Adis International

Access to resources Recommend Favorite

Risperidone Long-Acting Injection in the Treatment of First Episode Schizophrenia

By Rocca P. Sandei L. M. Bava I. Frieri T.

Current Psychopharmacology, Vol. 2, Iss. 1, 2013-02 ,pp. : 29-36

Bentham Science Publishers

Access to resources Recommend Favorite

Risperidone Long-Acting Injection in the Treatment of First Episode Schizophrenia

Current Psychopharmacology, Vol. 2, Iss. 1, 2013-02 ,pp. : 29-36

Bentham Science Publishers

Access to resources Recommend Favorite

Long-acting injectable risperidone extends time to relapse

Inpharma, Vol. 1, Iss. 1638, 2008-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia

By Bhanji N.H. Chouinard G. Margolese H.C.

European Neuropsychopharmacology, Vol. 14, Iss. 2, 2004-03 ,pp. : 87-92

Elsevier

Access to resources Recommend Favorite